A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...

A seminal study from researchers at the Icahn School of Medicine at Mount Sinai and their collaborators in the United Kingdom, Belgium, Spain, the Netherlands, and Iceland has uncovered a new genetic ...

Building on their landmark discovery of RNU4-2 / ReNU syndrome last year, the research team has identified the new, related disorder caused by mutations in the non-coding gene RNU2-2. RNU4-2 / ReNU ...

The AI Small Molecule Drug Discovery Center will focus on three core areas: designing novel drug-like molecules using generative AI, optimizing existing compounds to enhance their efficacy and safety, ...

Icahn School of Medicine at Mount Sinai is one of more than 800 institutions with graduate schools surveyed by U.S. News on an annual basis. Icahn School of Medicine at Mount Sinai confers degrees ...

See expanded profiles of nearly 1,800 schools. Unlock entering class stats including MCAT, GMAT and GRE scores.

Emma Young, MS, and Avner Schlessinger, PhD, conduct structural analysis of a novel drug target at the AI Small Molecule Drug ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development. The ...